Evaxion AS (EVAX)
3.20
+0.02
(+0.63%)
USD |
NASDAQ |
Oct 02, 16:00
3.25
+0.05
(+1.56%)
After-Hours: 20:00
Evaxion Net Income (Quarterly) : -3.724M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.724M |
| March 31, 2026 | -3.642M |
| December 31, 2025 | -5.914M |
| September 30, 2025 | 4.597M |
| June 30, 2025 | -4.896M |
| March 31, 2025 | -1.581M |
| December 31, 2024 | -3.604M |
| September 30, 2024 | -1.941M |
| June 30, 2024 | -6.194M |
| March 31, 2024 | 1.191M |
| December 31, 2023 | -4.56M |
| September 30, 2023 | -5.648M |
| June 30, 2023 | -5.677M |
| March 31, 2023 | -6.268M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.928M |
| September 30, 2022 | -5.711M |
| June 30, 2022 | -4.737M |
| March 31, 2022 | -5.777M |
| December 31, 2021 | -8.348M |
| September 30, 2021 | -5.233M |
| June 30, 2021 | -6.81M |
| March 31, 2021 | -4.082M |
| December 31, 2020 | -4.273M |
| September 30, 2020 | -4.066M |
| June 30, 2020 | -3.671M |
| March 31, 2020 | -3.099M |
| December 31, 2019 | -3.540M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -39.18M |
| Cellectis SA | -21.79M |
| Akari Therapeutics Plc | -4.816M |
| DBV Technologies SA | -- |
| Ascendis Pharma A/S | 240.65M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.724M |
| EPS Diluted (Quarterly) | -0.4464 |
| Enterprise Value | 19.79M |
| Earnings Yield | -32.92% |
| Normalized Earnings Yield | -33.08 |